Tower Research Capital LLC (Trc) Amgen Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Amgen Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 34,424 shares of AMGN stock, worth $9.07 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

34,424

Previous 67,716 49.16%

Holding current value

$9.07 Million

Previous $21.2 Million 47.58%

% of portfolio

0.3%

Previous 0.36%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $10.3 Million - $11.2 Million	-33,292 Reduced 49.16%	34,424 $11.1 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $3.07 Million - $3.73 Million	11,671 Added 20.82%	67,716 $21.2 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $12.8 Million - $15.4 Million	-47,522 Reduced 45.89%	56,045 $15.9 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $20.1 Million - $22.7 Million	78,592 Added 314.68%	103,567 $29.8 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $1.37 Million - $1.71 Million	-6,282 Reduced 20.1%	24,975 $6.71 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $1.61 Million - $1.91 Million	7,532 Added 31.75%	31,257 $6.94 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $657,500 - $801,382	2,912 Added 13.99%	23,725 $5.74 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $33.1 Million - $42.1 Million	-144,545 Reduced 87.41%	20,813 $5.47 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $12.1 Million - $13.7 Million	54,001 Added 48.49%	165,358 $37.3 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $28.3 Million - $31.4 Million	-122,473 Reduced 52.38%	111,357 $27.1 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $32.2 Million - $35.6 Million	146,736 Added 168.48%	233,830 $56.5 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $2.62 Million - $3 Million	13,185 Added 17.84%	87,094 $19.6 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $7.1 Million - $8.32 Million	-33,458 Reduced 31.16%	73,909 $15.7 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $4.52 Million - $5.01 Million	-19,341 Reduced 15.26%	107,367 $26.2 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $24.6 Million - $28.7 Million	110,857 Added 699.37%	126,708 $31.5 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $4.29 Million - $5.1 Million	-19,809 Reduced 55.55%	15,851 $3.64 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $5.57 Million - $6.19 Million	23,739 Added 199.14%	35,660 $9.06 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $2.01 Million - $2.46 Million	10,144 Added 570.85%	11,921 $2.81 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $173,856 - $230,581	954 Added 115.92%	1,777 $360,000
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $1.32 Million - $1.69 Million	-6,956 Reduced 89.42%	823 $198,000
Q3 2019 Nov 05, 2019	SELL	$174.11 - $208.62 $2.04 Million - $2.45 Million	-11,725 Reduced 60.12%	7,779 $1.51 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $1.9 Million - $2.22 Million	11,381 Added 140.11%	19,504 $3.59 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $1.62 Million - $1.82 Million	-8,948 Reduced 52.42%	8,123 $1.54 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $1.65 Million - $1.93 Million	-9,273 Reduced 35.2%	17,071 $3.32 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $1.63 Million - $1.83 Million	-8,773 Reduced 24.98%	26,344 $5.46 Million
Q2 2018 Aug 15, 2018	BUY	$166.05 - $186.51 $5.83 Million - $6.55 Million	35,117 New	35,117 $6.48 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $1.94 Million - $2.27 Million	-11,450 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $1.15 Million - $1.29 Million	6,817 Added 147.14%	11,450 $1.99 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $775,054 - $884,903	4,633	4,633 $864,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Amgen Inc Transaction History